Cusack Catherine 4

What Happened
Catherine Cusack, a director of Sabra Health Care REIT, was credited with 817 stock units on May 29, 2026 (transaction code A — award/grant). The reported acquisition price is $0.00, reflecting a non-cash grant of dividend-equivalent stock units rather than an open-market purchase.

Key Details

• Transaction date: 2026-05-29; reported on Form 4 filed 2026-06-02 (timely filing).
• Amount: 817 stock units credited; reporting price per unit listed as $0.00 (non-cash award).
• Footnote F1: These 817 units are dividend equivalent payments on previously granted stock units under the Issuer’s 2009 Performance Incentive Plan and will vest/payable on the same terms as the original awards.
• Footnote F2: The filing notes 726 unvested stock units and 54,290 vested stock units with payment deferred; each stock unit represents the right to receive one share of common stock.
• Transaction type: Dividend-equivalent stock unit credit (not a market purchase or sale).

Context
This is a compensation-related, non-cash grant (dividend equivalents) tied to prior equity awards; such credits do not indicate an immediate cash outlay or an open-market investment signal. The units will convert to shares (or be paid) according to the original award vesting/payment terms. The Form 4 appears to have been filed within the required reporting window.